Woodford R - Search Results

1

Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials.

Ledenko M, Antwi SO, Arima S, Driscoll J, Furuse J, Klümpen HJ, Larsen FO, Lau DK, Maderer A, Markussen A, Moehler M, Nooijen LE, Shaib WL, Tebbutt NC, André T, Ueno M, Woodford R, Yoo C, Zalupski MM, Patel T. Ledenko M, et al. Among authors: woodford r. Front Oncol. 2022 Aug 11;12:963753. doi: 10.3389/fonc.2022.963753. eCollection 2022. Front Oncol. 2022. PMID: 36033540 Free PMC article. No abstract available.

2

Validity and Efficiency of Progression-Free Survival-2 as a Surrogate End Point for Overall Survival in Advanced Cancer Randomized Trials.

Woodford R, Zhou D, Kok PS, Lord SJ, Friedlander M, Marschner I, Simes RJ, Lee CK. Woodford R, et al. JCO Precis Oncol. 2024 Jan;8:e2300296. doi: 10.1200/PO.23.00296. JCO Precis Oncol. 2024. PMID: 38207226

3

Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging.

Gjorup CA, Woodford R, Li I, Carlino MS, Ch'ng S, Chung D, Hsiao E, Lo SN, London K, Long GV, Menzies AM, Nieweg OE, Pennington TE, Rtshiladze MA, Saw RPM, Scolyer RA, Shannon KF, Spillane AJ, Stretch JR, Thompson JF, Varey AHR, van Akkooi ACJ. Gjorup CA, et al. Among authors: woodford r. Ann Surg Oncol. 2024 Mar;31(3):1857-1864. doi: 10.1245/s10434-023-14526-9. Epub 2023 Nov 15. Ann Surg Oncol. 2024. PMID: 37966706 Free PMC article.

4

PD-L1 expression as a prognostic marker in patients treated with chemotherapy for metastatic non-small-cell lung cancer.

Woodford R, Zhou D, Lord SJ, Marschner I, Cooper WA, Lewis CR, John T, Yang JC, Lee CK. Woodford R, et al. Future Oncol. 2022 May;18(14):1793-1799. doi: 10.2217/fon-2021-1184. Epub 2022 Feb 14. Future Oncol. 2022. PMID: 35156837 Review.

5

[No title available]

[No authors listed] [No authors listed] PMID: 38117390

6

Predictive value of PD-L1 and other clinical factors for chemoimmunotherapy in advanced non-small-cell lung cancer.

Woodford R, Loh Y, Lee J, Cooper W, Marschner I, Lewis CR, Millward M, Lord S, Gralla RJ, Yang JC, Mok T, Lee CK. Woodford R, et al. Future Oncol. 2019 Jul;15(20):2371-2383. doi: 10.2217/fon-2019-0105. Epub 2019 Jun 25. Future Oncol. 2019. PMID: 31354046

7

Disseminated intravascular coagulation complicating diagnosis of ROS1-mutant non-small cell lung cancer: A case report and literature review.

Woodford R, Lu M, Beydoun N, Cooper W, Liu Q, Lynch J, Kasherman L. Woodford R, et al. Thorac Cancer. 2021 Sep;12(17):2400-2403. doi: 10.1111/1759-7714.14071. Epub 2021 Jul 22. Thorac Cancer. 2021. PMID: 34291575 Free PMC article. Review.

8

The validity of progression-free survival 2 as a surrogate trial end point for overall survival.

Woodford RG, Zhou DD, Kok PS, Lord SJ, Friedlander M, Marschner IC, Simes RJ, Lee CK. Woodford RG, et al. Cancer. 2022 Apr 1;128(7):1449-1457. doi: 10.1002/cncr.34085. Epub 2022 Jan 5. Cancer. 2022. PMID: 34985773 Free article.

9

Combination chemotherapy with NAB^® -paclitaxel and capecitabine for patients with advanced biliary tract cancer (NAP-CAPABIL Pilot Study).

Woodford R, Brungs D, Leighton C, Grimison P, Sjoquist KM, Becker T, Robinson S, Gebski V, Wilson K, Chantrill L, Aghmesheh M. Woodford R, et al. Asia Pac J Clin Oncol. 2022 Oct;18(5):e220-e226. doi: 10.1111/ajco.13599. Epub 2021 Jun 28. Asia Pac J Clin Oncol. 2022. PMID: 34180586 Clinical Trial.

10

Immunotherapy-related gastritis: Two case reports and literature review.

Woodford R, Briscoe K, Tustin R, Jain A. Woodford R, et al. Clin Med Insights Oncol. 2021 Jul 9;15:11795549211028570. doi: 10.1177/11795549211028570. eCollection 2021. Clin Med Insights Oncol. 2021. PMID: 34290539 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page